KNSA Klasse A Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 28, 2026
$75,79
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$35,2052-Wochen-Tief
$82,9452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$5.91B
P/E (TTM)
77.3
EPS (TTM)
$0.98
Umsatz (TTM)
$841M
Ihre Abzeichen
52W-Spanne
$35–$83
Analystenbewertung
BUY
Kursziel
$98
P/E
77.3
ROE
14.0%
Nettogewinnmarge
9.6%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
KNSA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$75.79
Marktkapitalisierung (MRQ)
$5.91B
P/E (TTM)
77.3
EPS (TTM)
$0.98
Umsatz (TTM)
$841M
ROE (TTM)
14.0%
52W-Spanne
$35–$83
KNSA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$678M2021-12-31 → 2025-12-31
EPS$0.752019-12-31 → 2025-12-31
Freier Cashflow$136M2018-12-31 → 2025-12-31
Nettogewinnmarge9.6%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | KNSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 77.35-Jahres-Durchschnitt ≈22.1 | ≈22.1 | · | · | |
| P/S (TTM) | 7.05-Jahres-Durchschnitt ≈7.7 | ≈7.7 | · | · | |
| K/B (MRQ) | 9.05-Jahres-Durchschnitt ≈3.7 | ≈3.7 | · | · | |
| Kurs / FCF (TTM) | 32.35-Jahres-Durchschnitt ≈70.0 | ≈70.0 | · | · | |
| Kurs / Cashflow (TTM) | 32.05-Jahres-Durchschnitt ≈69.0 | ≈69.0 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 9.25-Jahres-Durchschnitt ≈3.9 | ≈3.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | KNSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 11.9%5-Jahres-Durchschnitt ≈-82.1% | ≈-82.1% | · | · | |
| EBITDA Margin (EBITDA-Marge) | 11.4%5-Jahres-Durchschnitt ≈-82.1% | ≈-82.1% | · | · | |
| Vorgewinnmarge (TTM) | 13.6%5-Jahres-Durchschnitt ≈-80.5% | ≈-80.5% | · | · | |
| Nettogewinnmarge (TTM) | 9.6%5-Jahres-Durchschnitt ≈-64.5% | ≈-64.5% | · | · | |
| ROA (TTM) | 10.4%5-Jahres-Durchschnitt ≈0.51% | ≈0.51% | · | · | |
| ROE (TTM) | 14.0%5-Jahres-Durchschnitt ≈-5.5% | ≈-5.5% | · | · | |
| ROIC | 9.0%5-Jahres-Durchschnitt ≈-8.6% | ≈-8.6% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | KNSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 3.95-Jahres-Durchschnitt ≈4.2 | ≈4.2 | · | · | |
| Quick Ratio (MRQ) | 3.25-Jahres-Durchschnitt ≈3.6 | ≈3.6 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | KNSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 60.1%5-Jahres-Durchschnitt ≈152.7% | ≈152.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 45.5% | · | · | · | |
| EPS YoY (EPS VjV) | -92.3% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | -92.3% | · | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -33.9% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -31.5% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | KNSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.05-Jahres-Durchschnitt ≈0.6 | ≈0.6 | · | · | |
| Inventory Turnover (Lagerumschlag) | 1.95-Jahres-Durchschnitt ≈3.0 | ≈3.0 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 23.65-Jahres-Durchschnitt ≈19.8 | ≈19.8 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.9M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
20.8%
Nächster Bericht
Okt 26, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 27, 2026 | $0.30 | $0.30 | -1.5% |
| 31. März 2026 | $0.27 | $0.21 | 31.5% | |
| 31. Dezember 2025 | $0.17 | $0.38 | -55.5% | |
| 30. September 2025 | $0.23 | $0.33 | -30.3% | |
| 30. Juni 2025 | $0.23 | $0.19 | 23.8% | |
| 31. März 2025 | $0.11 | $0.04 | 157.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $678M | $423M | $270M | $220M | $39M | |
| Cost of Revenue | $78M | $61M | $33M | $23M | $9M | |
| R&D Expense | $97M | $112M | $76M | $65M | $99M | |
| SG&A Expense | $196M | $168M | $129M | $98M | $86M | |
| Operating Income | $77M | $-46M | $-25M | $10M | $-157M | |
| Interest Income | $12M | $9M | $8M | $1M | $97.0K | |
| Pretax Income | $89M | $-36M | $-17M | $11M | $-157M | |
| Income Tax | $30M | $7M | $-31M | $-172M | $1M | |
| Net Income | $59M | $-43M | $14M | $183M | $-158M | |
| EPS (Basic) | $0.80 | $-0.60 | $0.20 | $2.64 | $-2.30 | |
| EPS (Diluted) | $0.75 | $-0.60 | $0.20 | $2.60 | $-2.30 | |
| Shares (Basic) | 74,200,924 | 71,424,159 | 70,058,952 | 69,382,275 | 68,576,810 | |
| Shares (Diluted) | 78,979,030 | 71,424,159 | 71,922,915 | 70,421,322 | 68,576,810 | |
| EBITDA | $77M | $-46M | $-25M | $10M | $-157M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $184M | $108M | $123M | $122M | |
| Short-term Investments | $248M | $60M | $98M | $68M | $60M | |
| Receivables | $16M | $42M | $21M | $13M | $4M | |
| Inventory | $55M | $26M | $31M | $22M | $4M | |
| Prepaid Expense | $43M | $20M | $18M | $11M | $7M | |
| Current Assets | $527M | $332M | $276M | $243M | $196M | |
| PP&E (Net) | $2M | $662.0K | $734.0K | $2M | $3M | |
| PP&E (Gross) | $9M | $9M | $9M | $9M | $9M | |
| Accum. Depreciation | $7M | $8M | $8M | $7M | $6M | |
| Intangibles | $15M | $16M | $17M | $18M | $19M | |
| Other Non-current Assets | $11M | $10M | $827.0K | $6M | $9M | |
| Total Assets | $764M | $581M | $526M | $460M | $233M | |
| Accounts Payable | $2M | $2M | $8M | $8M | $2M | |
| Accrued Liabilities | $42M | $32M | $28M | $30M | $38M | |
| Current Liabilities | $139M | $101M | $64M | $47M | $45M | |
| Capital Leases | $7M | $8M | $10M | $3M | $3M | |
| Other Non-current Liabilities | $19M | $2M | $2M | $2M | $270.0K | |
| Total Liabilities | $196M | $142M | $87M | $64M | $48M | |
| Paid-in Capital | $1.03B | $960M | $917M | $888M | $860M | |
| Retained Earnings | $-462M | $-521M | $-478M | $-492M | $-675M | |
| AOCI | $-25.0K | $-163.0K | $6.0K | $44.0K | $-66.0K | |
| Stockholders' Equity | $568M | $438M | $439M | $396M | $185M | |
| Liabilities + Equity | $764M | $581M | $526M | $460M | $233M | |
| Shares Outstanding | 76,294,164 | 72,516,059 | 70,460,617 | 69,697,503 | 69,060,403 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $37M | $31M | $27M | $25M | $25M | |
| Deferred Tax | $13M | $8M | $-34M | $-185M | $11.0K | |
| Operating Cash Flow | $138M | $26M | $13M | $6M | $-126M | |
| CapEx | $2M | $277.0K | $130.0K | $105.0K | $415.0K | |
| Investing Cash Flow | $-189M | $38M | $-30M | $-8M | $129M | |
| Financing Cash Flow | $33M | $12M | $1M | $3M | $6M | |
| Taxes Paid | $3M | $2M | $6M | $11M | $1M | |
| Free Cash Flow | $136M | $25M | $13M | $6M | $-127M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | 11.4% | -10.8% | -9.3% | 4.4% | -406.4% | |
| Net Margin | 8.7% | -10.2% | 5.2% | 83.3% | -409.7% | |
| Pretax Margin | 13.1% | -8.5% | -6.2% | 5.0% | -406.1% | |
| EBITDA Margin | 11.4% | -10.8% | -9.3% | 4.4% | -406.4% | |
| ROA | 8.8% | -7.8% | 2.9% | 53.0% | -54.2% | |
| ROE | 11.1% | -9.9% | 3.3% | 47.0% | -79.1% | |
| ROIC | 9.0% | -12.4% | 4.9% | 41.0% | -85.4% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.3 | 4.3 | 5.2 | 4.4 | |
| Quick Ratio | 3.1 | 2.8 | 3.6 | 4.3 | 4.2 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.8 | 0.5 | 0.6 | 0.1 | |
| Inventory Turnover | 1.9 | 2.1 | · | · | 5.0 | |
| Receivables Turnover | 23.6 | 13.4 | 15.9 | 26.5 | 19.3 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $7.44 | $6.05 | $6.23 | $5.68 | $2.68 | |
| Revenue / Share | $8.58 | $5.93 | $3.76 | $3.13 | $0.56 | |
| Cash Flow / Share | $1.75 | $0.36 | $0.18 | $0.08 | $-1.84 | |
| Cash / Share | $2.17 | $2.53 | $1.53 | $1.76 | $1.77 | |
| EPS (TTM) | $0.75 | $-0.60 | $0.20 | $2.60 | $-2.30 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 60.1% | 56.6% | 22.7% | 471.2% | · | |
| Revenue CAGR 3Y | 45.5% | 122.3% | · | · | · | |
| EPS YoY | · | · | -92.3% | · | · | |
| EPS CAGR 3Y | -33.9% | · | · | · | · | |
| Net Income YoY | · | · | -92.3% | · | · | |
| Net Income CAGR 3Y | -31.5% | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $678M | $423M | $270M | $220M | $39M | |
| Net Income TTM | $59M | $-43M | $14M | $183M | $-158M | |
| Market Cap | $3.15B | $1.43B | $1.24B | $1.04B | $813M | |
| P/E | 55.0 | -33.0 | 87.7 | 5.8 | -5.1 | |
| P/S | 4.6 | 3.4 | 4.6 | 4.7 | 21.1 | |
| P/B | 5.5 | 3.3 | 2.8 | 2.6 | 4.4 | |
| P / Tangible Book | 5.7 | 3.4 | 2.9 | 2.8 | 4.9 | |
| P / Cash Flow | 22.8 | 55.8 | 92.9 | 179.8 | -6.4 | |
| P / FCF | 23.1 | 56.4 | 93.8 | 183.1 | -6.4 | |
| Earnings Yield | 1.8% | -3.0% | 1.1% | 17.4% | -19.5% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $214M | $202M | $181M | $157M | $138M | $123M | $112M | $109M | $80M | $83M | $67M | $71M | $48M | $62M | $99M | |
| Cost of Revenue | $24M | $21M | $21M | $20M | $19M | $18M | $18M | $20M | $12M | $11M | $10M | $9M | $8M | $7M | $7M | $7M | |
| R&D Expense | $41M | $27M | $35M | $24M | $19M | $19M | $35M | $26M | $24M | $26M | $20M | $17M | $24M | $15M | $14M | $16M | |
| SG&A Expense | $64M | $61M | $57M | $49M | $47M | $44M | $41M | $46M | $42M | $39M | $37M | $34M | $29M | $29M | $27M | $25M | |
| Operating Income | $27M | $29M | $20M | $24M | $20M | $13M | $-19M | $-10M | $-117.0K | $-17M | $81.0K | $-11M | $-3M | $-11M | $6M | $46M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $771.0K | $322.0K | |
| Pretax Income | $31M | $33M | $23M | $27M | $23M | $16M | $-17M | $-7M | $2M | $-14M | $2M | $-8M | $-1M | $-9M | $7M | $47M | |
| Income Tax | $6M | $10M | $9M | $9M | $5M | $7M | $-8M | $5M | $6M | $3M | $-23M | $5M | $-16M | $3M | $2M | $-177M | |
| Net Income | $25M | $23M | $14M | $18M | $18M | $9M | $-9M | $-13M | $-4M | $-18M | $25M | $-14M | $15M | $-12M | $4M | $224M | |
| EPS (Basic) | $0.33 | $0.30 | $0.19 | $0.25 | $0.24 | $0.12 | $-0.11 | $-0.18 | $-0.06 | $-0.25 | $0.37 | $-0.20 | $0.21 | $-0.18 | $0.06 | $3.23 | |
| EPS (Diluted) | $0.30 | $0.27 | $0.18 | $0.23 | $0.23 | $0.11 | $-0.11 | $-0.18 | $-0.06 | $-0.25 | $0.37 | $-0.20 | $0.21 | $-0.18 | $0.07 | $3.18 | |
| Shares (Basic) | 77,577,675 | 76,516,535 | · | 74,714,846 | 73,438,530 | 72,647,121 | · | 71,726,685 | 71,004,640 | 70,633,023 | · | 70,186,016 | 69,918,287 | 69,751,697 | · | 69,445,071 | |
| Shares (Diluted) | 83,398,051 | 82,409,703 | · | 80,035,400 | 77,942,082 | 76,145,617 | · | 71,726,685 | 71,004,640 | 70,633,023 | · | 70,186,016 | 71,634,729 | 69,751,697 | · | 70,552,018 | |
| EBITDA | $27M | $29M | · | $24M | $20M | $13M | · | $-10M | $-117.0K | $-17M | · | $-11M | $-3M | $-11M | · | $46M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $176M | $190M | $166M | $175M | $192M | $157M | $184M | $97M | $99M | $141M | · | $118M | $113M | $81M | · | $176M | |
| Short-term Investments | $350M | $278M | $248M | $177M | $116M | $111M | $60M | $126M | $119M | $72M | · | $83M | $72M | $107M | · | $25M | |
| Receivables | $23M | $23M | $16M | $52M | $32M | $40M | $42M | $25M | $20M | $16M | · | $3M | $25M | $7M | · | $11M | |
| Inventory | $71M | $73M | $55M | $41M | $48M | $22M | $26M | $29M | $35M | $27M | · | $26M | $24M | $23M | · | $15M | |
| Prepaid Expense | $48M | $30M | $43M | $30M | $32M | $25M | $20M | $34M | $27M | $14M | · | $26M | $12M | $13M | · | $15M | |
| Current Assets | $669M | $594M | $527M | $476M | $420M | $356M | $332M | $311M | $301M | $271M | · | $256M | $246M | $232M | · | $242M | |
| PP&E (Net) | $3M | $2M | $2M | $2M | $1M | $606.0K | $662.0K | $561.0K | $625.0K | $712.0K | · | $918.0K | $1M | $1M | · | $2M | |
| PP&E (Gross) | $10M | $9M | $9M | $9M | $9M | $8M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Accum. Depreciation | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Intangibles | $15M | $15M | $15M | $16M | $16M | $16M | $16M | $16M | $17M | $17M | · | $18M | $18M | $18M | · | $18M | |
| Other Non-current Assets | $11M | $11M | $11M | $8M | $8M | $8M | $10M | $8M | $8M | $4M | · | $2M | $2M | $2M | · | $6M | |
| Total Assets | $896M | $825M | $764M | $712M | $661M | $599M | $581M | $555M | $542M | $520M | · | $483M | $484M | $443M | · | $460M | |
| Accounts Payable | $12M | $24M | $2M | $6M | $9M | $2M | $2M | $8M | $7M | $6M | · | $1M | $648.0K | $1M | · | $1M | |
| Accrued Liabilities | $47M | $33M | $42M | $31M | $36M | $22M | $32M | $40M | $33M | $45M | · | $41M | $35M | $21M | · | $31M | |
| Current Liabilities | $171M | $157M | $139M | $124M | $118M | $97M | $101M | $96M | $84M | $64M | · | $53M | $47M | $37M | · | $56M | |
| Capital Leases | $5M | $6M | $7M | $7M | $7M | $8M | $8M | $9M | $9M | $10M | · | $11M | $11M | $2M | · | $3M | |
| Other Non-current Liabilities | $34M | $25M | $19M | $15M | $9M | $5M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Total Liabilities | $242M | $220M | $196M | $177M | $166M | $142M | $142M | $118M | $107M | $88M | · | $78M | $73M | $53M | · | $76M | |
| Paid-in Capital | $1.07B | $1.05B | $1.03B | $1.01B | $990M | $970M | $960M | $949M | $935M | $928M | · | $908M | $901M | $894M | · | $881M | |
| Retained Earnings | $-414M | $-440M | $-462M | $-476M | $-495M | $-513M | $-521M | $-512M | $-500M | $-496M | · | $-503M | $-489M | $-504M | · | $-496M | |
| AOCI | $-1M | $-665.0K | $-25.0K | $-155.0K | $-53.0K | $-165.0K | $-163.0K | $-41.0K | $-130.0K | $-53.0K | · | $-1.0K | $13.0K | $55.0K | · | $-70.0K | |
| Stockholders' Equity | $654M | $606M | $568M | $535M | $495M | $457M | $438M | $437M | $435M | $432M | $439M | $405M | $412M | $390M | $396M | $384M | |
| Liabilities + Equity | $896M | $825M | $764M | $712M | $661M | $599M | $581M | $555M | $542M | $520M | · | $483M | $484M | $443M | · | $460M | |
| Shares Outstanding | 77,979,674 | 76,689,460 | 76,294,164 | 75,424,653 | 74,032,363 | 72,797,332 | 72,516,059 | 72,158,189 | 71,082,278 | 70,819,096 | 70,460,617 | 70,316,631 | 70,002,663 | 69,833,079 | 69,697,503 | 69,524,338 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $472.0K | $468.0K | $467.0K | $384.0K | $358.0K | $345.0K | $400.0K | $399.0K | $430.0K | $466.0K | $540.0K | $603.0K | $602.0K | $596.0K | $602.0K | $493.0K | |
| Stock-based Comp | $12M | $10M | $10M | $10M | $9M | $8M | $8M | $8M | $7M | $7M | $8M | $7M | $6M | $6M | $6M | $6M | |
| Deferred Tax | $3M | $5M | $3M | $4M | $3M | $3M | $-3M | $-4M | $11M | $4M | $-26M | $10M | $-19M | $1M | $348.0K | · | |
| Amort. of Intangibles | $250.0K | $250.0K | · | $250.0K | $250.0K | $250.0K | · | $250.0K | $250.0K | · | · | · | · | · | · | · | |
| Operating Cash Flow | $47M | $50M | $54M | $34M | $28M | $22M | $19M | $-2M | $5M | $4M | $4M | $17M | $-4M | $-4M | $-12M | $62M | |
| CapEx | $663.0K | $161.0K | $633.0K | $671.0K | $165.0K | $99.0K | $193.0K | $0 | $0 | $84.0K | $56.0K | $16.0K | $34.0K | $24.0K | $-32.0K | $22.0K | |
| Investing Cash Flow | $-74M | $-32M | $-71M | $-63M | $-4M | $-52M | $65M | $-6M | $-47M | $26M | $-15M | $-12M | $36M | $-38M | $-43M | $19M | |
| Financing Cash Flow | $12M | $6M | $8M | $12M | $11M | $3M | $2M | $7M | $-178.0K | $4M | $695.0K | $552.0K | $158.0K | $90.0K | $1M | $361.0K | |
| Taxes Paid | · | · | $3.0K | $0 | $1.0K | $3M | $1M | $-769.0K | · | · | $-1M | $201.0K | $4M | $3M | $6M | $1M | |
| Free Cash Flow | · | $50M | · | · | · | $22M | · | · | · | $4M | · | · | · | $-4M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.2% | 13.7% | · | 13.3% | 12.9% | 9.6% | · | -8.6% | -0.11% | -20.7% | · | -16.3% | -4.4% | -23.2% | · | 46.8% | |
| Net Margin | 10.4% | 10.5% | · | 10.2% | 11.4% | 6.2% | · | -11.3% | -3.6% | -22.2% | · | -20.7% | 20.9% | -25.4% | · | 226.0% | |
| Pretax Margin | 12.8% | 15.2% | · | 15.0% | 14.6% | 11.3% | · | -6.4% | 2.1% | -17.9% | · | -12.7% | -1.7% | -19.4% | · | 47.1% | |
| EBITDA Margin | 11.2% | 13.7% | · | 13.3% | 12.9% | 9.6% | · | -8.6% | -0.11% | -20.7% | · | -16.3% | -4.4% | -23.2% | · | 46.8% | |
| ROA | 3.3% | 3.2% | · | 2.9% | 3.0% | 1.5% | · | -2.4% | -0.76% | -3.7% | · | -2.9% | 4.3% | -3.6% | · | 62.9% | |
| ROE | 4.4% | 4.2% | · | 3.8% | 3.8% | 1.9% | · | -3.0% | -0.92% | -4.3% | · | -3.5% | 5.3% | -4.4% | · | 74.9% | |
| ROIC | 3.4% | 3.3% | · | 3.0% | 3.2% | 1.6% | · | -3.9% | 0.05% | -4.8% | · | -4.4% | 9.3% | -3.8% | · | 58.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 3.8 | · | 3.8 | 3.6 | 3.7 | · | 3.2 | 3.6 | 4.2 | · | 4.8 | 5.2 | 6.3 | · | 4.3 | |
| Quick Ratio | 3.2 | 3.1 | · | 3.3 | 2.9 | 3.2 | · | 2.6 | 2.8 | 3.6 | · | 3.8 | 4.4 | 5.3 | · | 3.8 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.1 | · | 0.3 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.6 | 0.4 | 0.7 | · | 0.7 | 0.4 | 0.4 | · | 0.5 | 0.4 | · | · | · | |
| Receivables Turnover | 8.8 | 6.8 | · | 4.7 | 6.0 | 4.9 | · | 8.0 | 4.8 | 6.8 | · | 9.4 | 4.4 | 2.6 | · | 13.8 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.39 | $7.90 | · | $7.10 | $6.69 | $6.28 | · | $6.06 | $6.12 | $6.10 | · | $5.76 | $5.88 | $5.59 | · | $5.52 | |
| Revenue / Share | $2.92 | $2.60 | · | $2.26 | $2.01 | $1.81 | · | $1.56 | $1.53 | $1.13 | · | $0.96 | $1.00 | $0.69 | · | $1.41 | |
| Cash Flow / Share | · | $0.61 | · | · | · | $0.29 | · | · | · | $0.06 | · | · | · | $-0.06 | · | · | |
| Cash / Share | $2.25 | $2.48 | · | $2.32 | $2.59 | $2.16 | · | $1.35 | $1.40 | $1.99 | · | $1.68 | $1.61 | $1.15 | · | $2.53 | |
| EPS (TTM) | $0.98 | $0.91 | · | $0.46 | $0.05 | $-0.24 | · | $-0.12 | $-0.14 | $0.13 | · | $-0.10 | $3.28 | $2.78 | · | $2.00 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $841M | $754M | · | $598M | $529M | $481M | · | $384M | $339M | $302M | · | $249M | $281M | $236M | · | $177M | |
| Net Income TTM | $81M | $73M | · | $36M | $5M | $-17M | · | $-9M | $-10M | $9M | · | $-7M | $231M | $196M | · | $143M | |
| Market Cap | $4.99B | $3.69B | · | $2.93B | $2.05B | $1.62B | · | $1.80B | $1.33B | $1.40B | · | $1.22B | $986M | $751M | · | $893M | |
| P/E | 65.3 | 52.9 | · | 84.4 | 553.4 | -92.5 | · | -208.2 | -133.4 | 151.8 | · | -173.7 | 4.3 | 3.9 | · | 6.4 | |
| P/S | 5.9 | 4.9 | · | 4.9 | 3.9 | 3.4 | · | 4.7 | 3.9 | 4.6 | · | 4.9 | 3.5 | 3.2 | · | 5.0 | |
| P/B | 7.6 | 6.1 | · | 5.5 | 4.1 | 3.5 | · | 4.1 | 3.1 | 3.2 | · | 3.0 | 2.4 | 1.9 | · | 2.3 | |
| P / Tangible Book | 7.8 | 6.3 | · | 5.6 | 4.3 | 3.7 | · | 4.3 | 3.2 | 3.4 | · | 3.2 | 2.5 | 2.0 | · | 2.4 | |
| P / Cash Flow | · | 73.6 | · | · | · | 72.4 | · | · | · | 350.5 | · | · | · | -176.1 | · | · | |
| Earnings Yield | 1.5% | 1.9% | · | 1.2% | 0.18% | -1.1% | · | -0.48% | -0.75% | 0.66% | · | -0.58% | 23.3% | 25.8% | · | 15.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $678M | $423M | $270M | $220M | $39M |
| Betriebsgewinnmarge % | 11.4% | -10.8% | -9.3% | 4.4% | -406.4% |
| Nettoergebnis | $59M | $-43M | $14M | $183M | $-158M |
| Verwässerte EPS | $0.75 | $-0.60 | $0.20 | $2.60 | $-2.30 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.8 | 3.3 | 4.3 | 5.2 | 4.4 |
| Quick Ratio | 3.1 | 2.8 | 3.6 | 4.3 | 4.2 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $136M | $25M | $13M | $6M | $-127M |
Institutionelle Eigentümer (13F) 280 Einreicher · $3.1B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
280
Gehaltener Wert
$3.1B
Neue Positionen
69
Geschlossene Positionen
26
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 69 (+25 vs. Vorquartal) | 26 (-7 vs. Vorquartal) | 89 (+16 vs. Vorquartal) | 77 (-8 vs. Vorquartal) | +321K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $445.818.527 | 6.971.361 | 14,50% | Aktien |
| Rubric Capital Management LP | $255.787.210 | 3.999.800 | 8,32% | Aktien |
| BAKER BROS. ADVISORS LP | $181.275.420 | 2.834.643 | 5,90% | Aktien |
| BlackRock, Inc. | $175.198.378 | 2.739.615 | 5,70% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $144.519.902 | 2.259.889 | 4,70% | Aktien |
| VANGUARD GROUP INC | $128.408.651 | 3.112.937 | 4,18% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $122.229.873 | 1.911.335 | 3,98% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $87.025.718 | 1.360.840 | 2,83% | Aktien |
| MORGAN STANLEY | $64.662.626 | 1.011.143 | 2,10% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $61.233.020 | 957.514 | 1,99% | Aktien |
| Spruce Street Capital LP | $58.710.577 | 918.070 | 1,91% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $55.937.333 | 874.786 | 1,82% | Aktien |
| Invesco Ltd. | $49.420.945 | 772.806 | 1,61% | Aktien |
| Driehaus Capital Management LLC | $45.928.826 | 718.199 | 1,49% | Aktien |
| STATE STREET CORP | $45.033.206 | 704.194 | 1,46% | Aktien |
| Point72 Asset Management, L.P. | $42.174.577 | 659.493 | 1,37% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $39.964.146 | 624.928 | 1,30% | Aktien |
| Pictet Asset Management Holding SA | $38.923.168 | 608.650 | 1,27% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $38.633.635 | 604.180 | 1,26% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $36.617.642 | 572.598 | 1,19% | Aktien |
| D. E. Shaw & Co., Inc. | $36.435.896 | 569.756 | 1,19% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $35.906.646 | 561.480 | 1,17% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $30.711.668 | 480.245 | 1,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $27.958.428 | 437.192 | 0,91% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $27.583.170 | 431.324 | 0,90% | Aktien |
| ORBIMED ADVISORS LLC | $26.897.370 | 420.600 | 0,87% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $26.778.671 | 556.151 | 0,87% | Aktien |
| BANK OF AMERICA CORP /DE/ | $26.437.633 | 413.411 | 0,86% | Aktien |
| OBERWEIS ASSET MANAGEMENT INC/ | $26.413.524 | 413.034 | 0,86% | Aktien |
| Aberdeen Group plc | $25.802.866 | 403.485 | 0,84% | Aktien |
| Fisher Asset Management, LLC | $25.469.110 | 398.266 | 0,83% | Aktien |
| DEUTSCHE BANK AG\ | $24.787.404 | 387.606 | 0,81% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $23.983.744 | 375.039 | 0,78% | Aktien |
| Penn Capital Management Company, LLC | $23.565.426 | 368.114 | 0,77% | Aktien |
| JANUS HENDERSON GROUP PLC | $23.197.334 | 481.023 | 0,75% | Aktien |
| NORTHERN TRUST CORP | $20.159.981 | 315.246 | 0,66% | Aktien |
| Balyasny Asset Management L.P. | $19.804.164 | 309.682 | 0,64% | Aktien |
| Qube Research & Technologies Ltd | $19.445.916 | 304.080 | 0,63% | Aktien |
| Caption Management, LLC | $19.172.210 | 299.800 | 0,62% | Verkaufsoption |
| NEW YORK STATE COMMON RETIREMENT FUND | $17.431.427 | 272.579 | 0,57% | Aktien |
| NOMURA HOLDINGS INC | $17.312.800 | 270.724 | 0,56% | Aktien |
| Soleus Capital Management, L.P. | $15.754.274 | 246.353 | 0,51% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $15.436.379 | 241.382 | 0,50% | Aktien |
| Bank of New York Mellon Corp | $14.870.367 | 232.531 | 0,48% | Aktien |
| Cubist Systematic Strategies, LLC | $14.806.633 | 381.319 | 0,48% | Aktien |
| ArrowMark Colorado Holdings LLC | $13.784.167 | 215.546 | 0,45% | Aktien |
| STEMPOINT CAPITAL LP | $13.380.514 | 209.234 | 0,44% | Aktien |
| GOLDMAN SACHS GROUP INC | $12.237.727 | 191.364 | 0,40% | Aktien |
| SEI INVESTMENTS CO | $12.058.768 | 188.565 | 0,39% | Aktien |
| BRAIDWELL LP | $11.755.417 | 183.822 | 0,38% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×7 Einreichungen | 26. Mai 2026 | 7,00% | Änderung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 19 Insider · 12 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Sanj K Patel | CHAIRMAN & CEO | 1. September 2026 M | 92.348 | 0 | 12 | $-39.426.213 |
| Mark Ragosa | CHIEF FINANCIAL OFFICER | 1. September 2026 M | 20.854 | 0 | 8 | $-5.557.371 |
| Chris Heberlig | EVP & CFO | 17. September 2019 A | 42.991 | 0 | 0 | $0 |
| Stephen F. Mahoney | President & COO | 17. September 2019 A | 79.589 | 0 | 0 | $0 |
| Ross Moat | CHIEF OPERATING OFFICER | 1. September 2026 M | 16.307 | 0 | 2 | $-194.502 |
| John Paolini | CHIEF MEDICAL OFFICER | 1. September 2026 M | 69.922 | 0 | 6 | $-7.996.373 |
| Michael R Megna | CHIEF ACCOUNTING OFFICER | 1. September 2026 M | 29.062 | 0 | 4 | $-2.641.483 |
| Dhiraj H Malkani | CHIEF STRATEGY OFFICER | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Eben Tessari | CHIEF STRATEGY OFFICER | 7. April 2026 M | 23.130 | 0 | 6 | $-1.489.360 |
| Arian Pano | Chief Clinical Dev. Officer | 2. September 2021 A | · | 0 | 0 | $0 |
| Thomas W. Beetham | EVP & Chief Legal Officer | 20. März 2021 A | 297.523 | 0 | 0 | $0 |
| Qasim Rizvi | Chief Commercial Officer | 31. Dezember 2020 M | 5.176 | 0 | 0 | $0 |
| Barry D Quart | Direktor | 19. August 2026 G | 12.745 | 0 | 8 | $-2.684.500 |
| Richard S Levy | Direktor | 1. August 2026 M | 22.359 | 0 | 0 | $0 |
| Bradley G Cole | Direktor | 29. Juli 2026 G | 7.172 | 0 | 1 | $-299.092 |
| Tracey L Mccain | Direktor | 29. Mai 2026 M | 15.345 | 0 | 0 | $0 |
| Thomas Malley | Direktor | 29. Mai 2026 M | 15.345 | 0 | 0 | $0 |
| Kimberly J Popovits | Direktor | 29. Mai 2026 M | 15.345 | 0 | 0 | $0 |
| Carsten Boess | 10%-Eigentümer | 29. Mai 2018 C | 79.589 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 25 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,24% | 3.411 SH | 2. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,21% | 399.537 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,16% | 45.447 SH | 19. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,11% | 3.771 SH | 2. Oktober 2026 | Täglich |
| IWM · iShares Trust | 0,11% | 1.082.567 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,10% | 20.296 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,08% | 244.007 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,07% | 149.712 NS | 31. Juli 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,07% | 551.977 SH | 19. August 2026 | Täglich |
| ISCG · iShares Trust | 0,07% | 8.664 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 14.033 SH | 2. Oktober 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,03% | 955.916 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 110.484 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 2.097 SH | 11. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 88.365 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 3.131 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 1.652 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 8.599 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 11.356 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 11.390 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.318.886 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.504 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 1.878 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 3.056 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 15.367 SH | 1. September 2026 | Täglich |
KNSA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$98.50
+30,0%
5 35,7%
Starker Kauf
8 57,1%
Kauf
1 7,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
8 Analysten · 2026-09-29Mittelwert-Ziel $98.00 +29,3%
← Unter allen Zielen
Aktueller Preis $75.79
Tief$87.00
Mittelwert$98.00
Hoch$108.00
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 28, 2026